BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11138402)

  • 1. [Circulating leptin doesn not change in postmenopausal women receiving replacement therapy with tibolone].
    Basurto L; Galván R; Ochoa R; Fonseca E; Zárate A
    Ginecol Obstet Mex; 2000 Oct; 68():416-9. PubMed ID: 11138402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
    Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does tibolone affect serum leptin levels and body weight in postmenopausal women?
    Gol M; Ozsener S; Sendag F; Uretmen S; Oztekin K; Tanyalcin T; Bilgin O
    Arch Gynecol Obstet; 2005 Jul; 272(2):127-30. PubMed ID: 15517326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV; Christodoulakos GE; Economou EV; Vlachou SA; Panoulis CP; Alexandrou AP; Kouskouni EE; Creatsas GC
    Maturitas; 2008 Jan; 59(1):62-71. PubMed ID: 18164562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
    Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
    Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
    Dedeoğlu EN; Erenus M; Yörük P
    Fertil Steril; 2009 Feb; 91(2):425-31. PubMed ID: 18249383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Creatsa MG; Economou EV; Siasou Z; Panoulis CP; Kalligerou I; Papadias C
    Climacteric; 2008 Apr; 11(2):155-65. PubMed ID: 18365858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of hormone replacement with tibolone on plasma insulin and blood glucose in postmenopause].
    Saucedo RP; Basurto L; Fonseca E; Zárate A
    Ginecol Obstet Mex; 2001 Aug; 69():301-3. PubMed ID: 11599314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugated estrogens and tibolone modify the gonadotrophin glycosylation pattern in postmenopausal women.
    Hernandez-Valencia M; Zarate A; Sandoval A; Ruiz M; Timossi C; Amato D; Basurto L
    Gynecol Obstet Invest; 2007; 63(1):22-7. PubMed ID: 16864983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raloxifene increases serum leptin levels in postmenopausal women: a prospective study.
    Cakmak A; Posaci C; Dogan E; Caliskan S; Guclu S; Altunyurt S
    Am J Obstet Gynecol; 2005 Aug; 193(2):347-51. PubMed ID: 16098853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor (IGF)-I levels in postmenopausal women receiving tibolone.
    Hopkins KD; Parker JR; Lehmann ED; Rymer J; Holly JM; Fogelman I; Cwyfan-Hughes S; Teale JD; Gosling RG
    Horm Metab Res; 1995 Aug; 27(8):387-8. PubMed ID: 7590630
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-alpha and hepatocyte growth factor in postmenopausal women.
    Sezer Ozer K; Erenus M; Yoldemir T
    Climacteric; 2009 Feb; 12(1):66-71. PubMed ID: 19012050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
    Jamin C; Bourg F; Legeai J; Senoussi S
    Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.